Bristol-Myers Squibb Co. (BMY) | Common-Size Income Statement

See also

ˇ Show More

You have visited 10 password protected pages for free. Others contain data covered by .

Bristol-Myers Squibb Co., Common-Size Consolidated Income Statement

	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Net sales
Cost of products sold
Gross profit	%	%	%	%	%
Marketing, selling and administrative
Advertising and product promotion
Research and development
Acquired in-process research and development
Provision for restructuring
Litigation expense, net
Equity in net income of affiliates
Gain on sale of ImClone shares
Impairment and loss on sale of manufacturing operations
Gain (loss) on debt repurchase
Auction Rate Securities (ARS) impairment
Net foreign exchange transaction (gains) losses
Gain on sale of product lines, businesses and assets
Acquisition related items
Other income from alliance partners
Pension curtailment and settlement charges
Other
Other income (expense)	%	%	%	%	%
Earnings from continuing operations before interest and income taxes	%	%	%	%	%
Interest expense
Interest income
Earnings from continuing operations before income taxes	%	%	%	%	%
Provision for income taxes
Net earnings from continuing operations	%	%	%	%	%
Net earnings from discontinued operations
Net earnings	%	%	%	%	%
Net earnings attributable to noncontrolling interest
Net earnings attributable to Bristol-Myers Squibb Company	%	%	%	%	%